Insider trading

Period: 120 months Stock: DXCM + Add filter Clear all

Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in

When Periodin use

Who Role

The trade Type of trade Minimum amount Plan Share of their own holding

Ownership What the chief executive holds

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months

605 decisions over 120 months

Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners

605 decisions over 120 months

The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any605 Buys3 Sells602 Cluster buys

605 decisions over 120 months

The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more

605 decisions over 120 months

The trade

Plan

Discretionary: they chose to sell that week.
Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.

Any Discretionary Scheduled (10b5-1) Not stated Not on a plan

605 decisions over 120 months

The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

605 decisions over 120 months

Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

605 decisions over 120 months

Stock

Insider

Type ?

Of own stake ↓

Why it stands out

24 Nov 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$45.54K 411 at 110.80

0.3%

Not planned

22 Nov 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$129.36K 1,176 at 110.00

1.5%

Not planned

15 Nov 2023

ALTMAN STEVEN R Director · indirect

Sold at will

$101.26K 1,000 at 101.26

1.6%

Not planned

9 Nov 2023

Naganathan Girish EVP Chief Technology Officer

Sold at will

$254.16K 2,725 at 93.27

5.4%

Not planned

8 Nov 2023

Regan Barry J. EVP Operations

Sold at will

$192.25K 2,019 at 95.22

3.0%

Not planned

23 Oct 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$35.24K 411 at 85.75

0.3%

Not planned

16 Oct 2023

ALTMAN STEVEN R Director · indirect

Sold on a plan

$77.58K 1,000 at 77.58

1.6%

Planned (10b5-1)

22 Sep 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$36.33K 411 at 88.40

0.3%

Not planned

15 Sep 2023

ALTMAN STEVEN R Director · indirect

Sold at will

$101.50K 1,000 at 101.50

1.6%

Not planned

12 Sep 2023

Heller Bridgette P Director

Sold on a plan

$63.94K 600 at 106.56

2.5%

Planned (10b5-1)

1 Sep 2023

Dolan Matthew Vincent SVP Corporate Strategy-Develop

Sold at will

$5.73K 56 at 102.32

0.2%

Not planned

23 Aug 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$43.99K 411 at 107.03

0.3%

Not planned

22 Aug 2023

Sylvain Jereme M EVP Chief Financial Officer

Sold at will

$192.48K 1,844 at 104.38

2.5%

Not planned

9 Aug 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$43.40K 392 at 110.71

0.5%

Not planned

24 Jul 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$53.80K 412 at 130.58

0.3%

Not planned

14 Jul 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$684.22K 5,031 at 136.00

3.8%

Not planned

10 Jul 2023

Regan Barry J. EVP Operations

Sold at will

$254.69K 1,989 at 128.05

2.9%

Not planned

10 Jul 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$50.20K 392 at 128.05

0.5%

Not planned

23 Jun 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$51.88K 412 at 125.92

0.3%

Not planned

15 Jun 2023

Selvaraj Shelly Ramasamy SVP Chief Information Officer

Sold at will

$274.95K 2,115 at 130.00

4.0%

Not planned

9 Jun 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$47.67K 393 at 121.31

0.5%

Not planned

23 May 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$48.88K 412 at 118.65

0.3%

Not planned

22 May 2023

Sylvain Jereme M EVP Chief Financial Officer

Sold at will

$282.19K 2,400 at 117.58

3.1%

Not planned

9 May 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$47.23K 393 at 120.19

0.5%

Not planned

27 Apr 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$633.91K 5,031 at 126.00

3.7%

Not planned

24 Apr 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$51.37K 412 at 124.68

0.3%

Not planned

20 Apr 2023

Leach Jacob Steven EVP Chief Technology Officer

Sold at will

$3.85M 30,764 at 125.00

10.6%

Not planned

20 Apr 2023

Regan Barry J. EVP Operations

Sold at will

$275.64K 2,214 at 124.50

3.1%

Not planned

20 Apr 2023

Selvaraj Shelly Ramasamy SVP Chief Information Officer

Sold at will

$250.88K 2,007 at 125.00

3.7%

Not planned

17 Apr 2023

Flynn Paul R EVP Global Revenue

Sold at will

$333.72K 2,781 at 120.00

5.1%

Not planned

10 Apr 2023

Stern Sadie EVP Chief Human Resources Offi

Sold at will

$44.15K 393 at 112.35

0.5%

Not planned

3 Apr 2023

SAYER KEVIN R President CEO and Chairman of

Sold at will 3×

$2.38M 20,812 at 114.46

6.0%

Not planned

3 Apr 2023

Brown Michael Jon EVP Chief Legal Officer

Sold at will 3×

$413.49K 3,612 at 114.48

5.5%

Not planned

23 Mar 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold at will

$633.45K 5,442 at 116.40

3.8%

Not planned

16 Mar 2023

Dolan Matthew Vincent SVP Corporate Strategy-Develop

Sold, plan not stated

$264.85K 2,303 at 115.00

6.4%

14 Mar 2023

Stern Sadie EVP Chief Human Resources Offi

Sold, plan not stated

$43.96K 393 at 111.86

0.5%

13 Mar 2023

Dolan Matthew Vincent SVP Corporate Strategy-Develop

Sold, plan not stated

$661.96K 6,229 at 106.27

14.8%

13 Mar 2023

Flynn Paul R EVP Global Revenue

Sold, plan not stated

$295.64K 2,782 at 106.27

4.8%

13 Mar 2023

Regan Barry J. EVP Operations

Sold, plan not stated

$213.60K 2,010 at 106.27

2.8%

6 Mar 2023

Leach Jacob Steven EVP Chief Technology Officer

Sold, plan not stated 2×

$2.08M 18,144 at 114.74

6.1%

6 Mar 2023

Dolan Matthew Vincent SVP Corporate Strategy-Develop

Sold, plan not stated

$25.85K 226 at 114.40

0.8%

1 Mar 2023

SAYER KEVIN R President CEO and Chairman of

Sold, plan not stated 2×

$4.23M 38,464 at 109.94

10.4%

23 Feb 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold, plan not stated

$46.00K 412 at 111.64

0.3%

22 Feb 2023

Sylvain Jereme M EVP Chief Financial Officer

Sold, plan not stated

$274.90K 2,400 at 114.54

3.6%

30 Jan 2023

SAYER KEVIN R President CEO and Chairman of

Sold, plan not stated 2×

$6.03M 56,844 at 106.15

13.3%

30 Jan 2023

Regan Barry J. EVP Operations

Sold, plan not stated

$234.84K 2,213 at 106.12

3.6%

23 Jan 2023

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold, plan not stated

$44.44K 412 at 107.86

0.3%

20 Jan 2023

SAYER KEVIN R President CEO and Chairman of

Sold, plan not stated

$4.82M 45,607 at 105.75

9.7%

23 Dec 2022

Pacelli Steven Robert EVP Managing Director Dexcom V

Sold, plan not stated

$46.38K 412 at 112.57

0.3%

8 Dec 2022

Flynn Paul R EVP Global Revenue

Sold, plan not stated

$1.11M 8,988 at 123.50

13.9%

Showing 101–150 of 605.